Zimmer Biomet Holdings Basic Shares Outstanding 2010-2025 | ZBH
Zimmer Biomet Holdings annual/quarterly basic shares outstanding history and growth rate from 2010 to 2025. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
- Zimmer Biomet Holdings basic shares outstanding for the quarter ending March 31, 2025 were $0.199B, a 3.07% decline year-over-year.
- Zimmer Biomet Holdings basic shares outstanding for the twelve months ending March 31, 2025 were $810M, a 2.57% decline year-over-year.
- Zimmer Biomet Holdings annual basic shares outstanding for 2024 were $0.203B, a 2.68% decline from 2023.
- Zimmer Biomet Holdings annual basic shares outstanding for 2023 were $0.209B, a 0.43% decline from 2022.
- Zimmer Biomet Holdings annual basic shares outstanding for 2022 were $0.21B, a 0.48% increase from 2021.
| Zimmer Biomet Holdings Annual Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024 | $203 |
| 2023 | $209 |
| 2022 | $210 |
| 2021 | $209 |
| 2020 | $207 |
| 2019 | $205 |
| 2018 | $204 |
| 2017 | $202 |
| 2016 | $200 |
| 2015 | $187 |
| 2014 | $169 |
| 2013 | $170 |
| 2012 | $175 |
| 2011 | $188 |
| 2010 | $200 |
| 2009 | $215 |
| Zimmer Biomet Holdings Quarterly Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2025-03-31 | $199 |
| 2024-12-31 | $203 |
| 2024-09-30 | $202 |
| 2024-06-30 | $206 |
| 2024-03-31 | $205 |
| 2023-12-31 | $209 |
| 2023-09-30 | $209 |
| 2023-06-30 | $209 |
| 2023-03-31 | $209 |
| 2022-12-31 | $210 |
| 2022-09-30 | $210 |
| 2022-06-30 | $210 |
| 2022-03-31 | $209 |
| 2021-12-31 | $209 |
| 2021-09-30 | $209 |
| 2021-06-30 | $209 |
| 2021-03-31 | $208 |
| 2020-12-31 | $207 |
| 2020-09-30 | $207 |
| 2020-06-30 | $207 |
| 2020-03-31 | $207 |
| 2019-12-31 | $205 |
| 2019-09-30 | $205 |
| 2019-06-30 | $205 |
| 2019-03-31 | $204 |
| 2018-12-31 | $204 |
| 2018-09-30 | $204 |
| 2018-06-30 | $203 |
| 2018-03-31 | $203 |
| 2017-12-31 | $202 |
| 2017-09-30 | $202 |
| 2017-06-30 | $202 |
| 2017-03-31 | $201 |
| 2016-12-31 | $200 |
| 2016-09-30 | $200 |
| 2016-06-30 | $199 |
| 2016-03-31 | $200 |
| 2015-12-31 | $187 |
| 2015-09-30 | $204 |
| 2015-06-30 | $173 |
| 2015-03-31 | $170 |
| 2014-12-31 | $169 |
| 2014-09-30 | $169 |
| 2014-06-30 | $168 |
| 2014-03-31 | $169 |
| 2013-12-31 | $170 |
| 2013-09-30 | $170 |
| 2013-06-30 | $169 |
| 2013-03-31 | $169 |
| 2012-12-31 | $175 |
| 2012-09-30 | $174 |
| 2012-06-30 | $175 |
| 2012-03-31 | $177 |
| 2011-12-31 | $188 |
| 2011-09-30 | $188 |
| 2011-06-30 | $192 |
| 2011-03-31 | $193 |
| 2010-12-31 | $200 |
| 2010-09-30 | $199 |
| 2010-06-30 | $202 |
| 2010-03-31 | $203 |
| 2009-12-31 | $215 |
| 2009-09-30 | $214 |
| 2009-06-30 | $215 |
| 2009-03-31 | $222 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.255B | $7.679B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.503B | 27.84 |
| Boston Scientific (BSX) | United States | $154.040B | 38.56 |
| Stryker (SYK) | United States | $144.095B | 30.13 |
| EssilorLuxottica (ESLOY) | France | $132.622B | 0.00 |
| Medtronic (MDT) | Ireland | $105.579B | 15.42 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.866B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.124B | 27.36 |
| ResMed (RMD) | United States | $35.477B | 26.65 |
| GE HealthCare Technologies (GEHC) | United States | $30.720B | 14.59 |
| Agilent Technologies (A) | United States | $30.004B | 19.82 |
| Terumo (TRUMY) | Japan | $29.197B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.643B | 16.28 |
| Insulet (PODD) | United States | $18.215B | 77.74 |
| Baxter (BAX) | United States | $15.352B | 11.47 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.456B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.179B | 17.65 |
| Bio-Rad Laboratories (BIO) | United States | $6.487B | 21.93 |
| Prestige Consumer Healthcare (PBH) | United States | $4.014B | 19.16 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.368B | 9.64 |
| ICU Medical (ICUI) | United States | $3.306B | 28.16 |
| Haemonetics (HAE) | United States | $3.194B | 15.03 |
| Envista Holdings (NVST) | United States | $2.778B | 23.08 |
| GN Store Nord (GNNDY) | Denmark | $2.069B | 17.14 |
| LeMaitre Vascular (LMAT) | United States | $1.855B | 41.46 |
| QuidelOrtho (QDEL) | United States | $1.750B | 14.65 |
| AtriCure (ATRC) | United States | $1.478B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.281B | 20.17 |
| AdaptHealth (AHCO) | United States | $1.194B | 12.12 |
| Neogen (NEOG) | United States | $1.192B | 15.25 |
| Kestra Medical Technologies (KMTS) | United States | $1.139B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.043B | 0.00 |
| InMode (INMD) | Israel | $0.995B | 9.11 |
| Phibro Animal Health (PAHC) | United States | $0.771B | 11.83 |
| Evolus (EOLS) | United States | $0.749B | 0.00 |
| Owens & Minor (OMI) | United States | $0.596B | 5.07 |
| Curaleaf Holdings (CURLF) | Canada | $0.579B | 0.00 |
| CeriBell (CBLL) | United States | $0.568B | 0.00 |
| Valneva SE (VALN) | France | $0.542B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.518B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.424B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.420B | 0.00 |
| Surmodics (SRDX) | United States | $0.391B | 0.00 |
| Omeros (OMER) | United States | $0.370B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.340B | 14.75 |
| Capricor Therapeutics (CAPR) | United States | $0.333B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.302B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.292B | 26.43 |
| Sanara MedTech (SMTI) | United States | $0.283B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.262B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.259B | 46.10 |
| ZimVie (ZIMV) | United States | $0.245B | 14.65 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.217B | 0.00 |
| Quanterix (QTRX) | United States | $0.208B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.184B | 4.21 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.16 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Brainsway (BWAY) | Israel | $0.162B | 50.65 |
| Organigram Global (OGI) | Canada | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.146B | 17.99 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.117B | 0.00 |
| Exagen (XGN) | United States | $0.116B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.091B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.086B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.58 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.061B | 0.00 |
| United Health Products (UEEC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 55.50 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 11.14 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |